Center for Substance Abuse Prevention; Notice of Meeting, 5471 [2013-01477]
Download as PDF
Federal Register / Vol. 78, No. 17 / Friday, January 25, 2013 / Notices
Dated: January 17, 2013.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2013–01433 Filed 1–24–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
mstockstill on DSK4VPTVN1PROD with
Center for Substance Abuse
Prevention; Notice of Meeting
Pursuant to Public Law 92–463,
notice is hereby given that the
Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Center for Substance Abuse Prevention
(CSAP) Drug Testing Advisory Board
(DTAB) will meet on February 11, 2013,
from 10:30 a.m. to 4:30 p.m. and
February 12, 2013, from 9:00 a.m. to
2:00 p.m. E.S.T. The DTAB will convene
in both open and closed sessions over
these two days.
On February 11, 2013, from 10:30 a.m.
to 4:30 p.m., the meeting will be open
to the public and will include updates
on the proposed revisions to the
Mandatory Guidelines for Federal
Workplace Drug Testing Programs, the
custody and control form, and the
medical review officer certification. The
meeting also will include federal drug
testing updates from the Department of
Transportation, the Department of
Defense, the Nuclear Regulatory
Commission, and the Federal Drug-Free
Workplace Programs.
The public is invited to attend the
open session in person or to listen via
teleconference. Due to the limited
seating space and call-in capacity,
registration is requested. Public
comments are welcome. To register,
make arrangements to attend, obtain the
teleconference call-in numbers and
access codes, submit written or brief
oral comments, or request special
accommodations for persons with
disabilities, please register at the
SAMHSA Advisory Committee’s Web
site at https://nac.samhsa.gov/
Registration/meetingsRegistration.aspx
or contact the CSAP DTAB Designated
Federal Official, Dr. Janine Denis Cook
(see contact information below).
On February 12, 2013, between 9:00
a.m. and 2:00 p.m., the Board will meet
in closed session to discuss proposed
revisions to the Mandatory Guidelines
for Federal Workplace Drug Testing
Programs. Therefore, this portion of the
meeting is closed to the public as
determined by the Administrator,
SAMHSA, in accordance with 5 U.S.C.
VerDate Mar<15>2010
18:39 Jan 24, 2013
Jkt 229001
552b(c)(9)(B) and 5 U.S.C. App. 2,
Section 10(d).
Meeting information and a roster of
DTAB members may be obtained by
accessing the SAMHSA Advisory
Committee’s Web site, https://
www.nac.samhsa.gov/DTAB/
meetings.aspx, or by contacting Dr.
Cook.
Committee Name: Substance Abuse and
Mental Health Services Administration’s
Center for Substance Abuse Prevention, Drug
Testing Advisory Board.
Dates/Time/Type: February 11, 2013, from
10:30 a.m. to 4:30 p.m. E.S.T.: Open;
February 12, 2013, from 9:00 a.m. to 2:00
p.m. E.S.T.: Closed.
Place: Sugarloaf Conference Room,
SAMHSA Office Building, 1 Choke Cherry
Road, Rockville, Maryland 20857.
Contact: Janine Denis Cook, Ph.D.,
Designated Federal Official, CSAP Drug
Testing Advisory Board, 1 Choke Cherry
Road, Room 7–1043, Rockville, Maryland
20857, Telephone: 240–276–2600, Fax: 240–
276–2610, Email:
janine.cook@samhsa.hhs.gov.
Janine Denis Cook,
Designated Federal Official, DTAB, Division
of Workplace Programs, Center for Substance
Abuse Prevention, Substance Abuse and
Mental Health Services Administration.
[FR Doc. 2013–01477 Filed 1–24–13; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2012–1091]
Availability of Draft Environmental
Assessment for the Proposed
Modification of the Bayonne Bridge
Across the Kill Van Kull Between
Bayonne, Hudson County, NJ and
Staten Island, Richmond County, NY
Coast Guard, DHS.
Notice of availability extending
comment period and notice of third
public meeting.
AGENCY:
ACTION:
This notice extends the public
comment period on a Draft
Environmental Assessment (Draft EA)
which examines the reasonably
foreseeable environmental impacts and
socio-economic impacts of the proposed
modification of the historic Bayonne
Bridge across the Kill Van Kull between
Bayonne, New Jersey and Staten Island,
New York. This notice also announces
a third public meeting, in Newark, NJ,
on this Draft EA. Because the Bayonne
Bridge is a structure over navigable
waters of the United States, the
proposed bridge modification would
require a Coast Guard Bridge Permit
SUMMARY:
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
5471
Amendment. This notice provides
information on how to participate in the
public comment process for the Draft
EA, which includes an opportunity to
submit oral or written comments at
three public meetings to consider an
application by the Port Authority of
New York & New Jersey (PANYNJ) for
Coast Guard approval of the
modification to the Bayonne Bridge
across the Kill Van Kull.
DATES: Written comments and related
material may be submitted to our online
docket via https://www.regulations.gov
on or before March 5, 2013, or must
reach the Docket Management Facility
by that date.
The public meetings will be held on
February 5, 2013, in Bayonne, NJ,
February 7, 2013, in Staten Island, NY,
and February 13, 2013, in Newark, NJ
(see the Background and Purpose
section below for more details). As
previously noted for the first two
meetings, any requests for an oral or
sign language interpreter must be
received by January 25, 2013. Such
requests for the February 13, 2013
meeting in Newark, NJ, must be
received by February 1, 2013.
ADDRESSES: You may submit comments
identified by docket number USCG–
2012–1091 using any one of the
following methods:
(1) Federal eRulemaking Portal:
https://www.regulations.gov.
(2) Fax: 202–493–2251.
(3) Mail: Docket Management Facility
(M–30), U.S. Department of
Transportation, West Building Ground
Floor, Room W12–140, 1200 New Jersey
Avenue SE., Washington, DC 20590–
0001.
(4) Hand delivery: Same as mail
address above, between 9 a.m. and 5
p.m., Monday through Friday, except
Federal holidays. The telephone number
is 202–366–9329.
To avoid duplication, please use only
one of these four methods. See the
‘‘Public Participation and Request for
Comments’’ portion of the
SUPPLEMENTARY INFORMATION section
below for instructions on submitting
comments.
We have provided a copy of the Draft
EA (document USCG–2012–1091–0002)
in our online docket at https://
www.regulations.gov. Also, the Coast
Guard First District Bridge Office at 1
South Street Bldg 1, New York, NY
10004–1466 will maintain a printed
copy of the Draft EA for public review.
The document will be available for
inspection at this location between 8
a.m. and 4 p.m., Monday through
Friday, except Federal holidays. The
document will also be available for
E:\FR\FM\25JAN1.SGM
25JAN1
Agencies
[Federal Register Volume 78, Number 17 (Friday, January 25, 2013)]
[Notices]
[Page 5471]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-01477]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Center for Substance Abuse Prevention; Notice of Meeting
Pursuant to Public Law 92-463, notice is hereby given that the
Substance Abuse and Mental Health Services Administration's (SAMHSA)
Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory
Board (DTAB) will meet on February 11, 2013, from 10:30 a.m. to 4:30
p.m. and February 12, 2013, from 9:00 a.m. to 2:00 p.m. E.S.T. The DTAB
will convene in both open and closed sessions over these two days.
On February 11, 2013, from 10:30 a.m. to 4:30 p.m., the meeting
will be open to the public and will include updates on the proposed
revisions to the Mandatory Guidelines for Federal Workplace Drug
Testing Programs, the custody and control form, and the medical review
officer certification. The meeting also will include federal drug
testing updates from the Department of Transportation, the Department
of Defense, the Nuclear Regulatory Commission, and the Federal Drug-
Free Workplace Programs.
The public is invited to attend the open session in person or to
listen via teleconference. Due to the limited seating space and call-in
capacity, registration is requested. Public comments are welcome. To
register, make arrangements to attend, obtain the teleconference call-
in numbers and access codes, submit written or brief oral comments, or
request special accommodations for persons with disabilities, please
register at the SAMHSA Advisory Committee's Web site at https://nac.samhsa.gov/Registration/meetingsRegistration.aspx or contact the
CSAP DTAB Designated Federal Official, Dr. Janine Denis Cook (see
contact information below).
On February 12, 2013, between 9:00 a.m. and 2:00 p.m., the Board
will meet in closed session to discuss proposed revisions to the
Mandatory Guidelines for Federal Workplace Drug Testing Programs.
Therefore, this portion of the meeting is closed to the public as
determined by the Administrator, SAMHSA, in accordance with 5 U.S.C.
552b(c)(9)(B) and 5 U.S.C. App. 2, Section 10(d).
Meeting information and a roster of DTAB members may be obtained by
accessing the SAMHSA Advisory Committee's Web site, https://www.nac.samhsa.gov/DTAB/meetings.aspx, or by contacting Dr. Cook.
Committee Name: Substance Abuse and Mental Health Services
Administration's Center for Substance Abuse Prevention, Drug Testing
Advisory Board.
Dates/Time/Type: February 11, 2013, from 10:30 a.m. to 4:30 p.m.
E.S.T.: Open; February 12, 2013, from 9:00 a.m. to 2:00 p.m. E.S.T.:
Closed.
Place: Sugarloaf Conference Room, SAMHSA Office Building, 1
Choke Cherry Road, Rockville, Maryland 20857.
Contact: Janine Denis Cook, Ph.D., Designated Federal Official,
CSAP Drug Testing Advisory Board, 1 Choke Cherry Road, Room 7-1043,
Rockville, Maryland 20857, Telephone: 240-276-2600, Fax: 240-276-
2610, Email: janine.cook@samhsa.hhs.gov.
Janine Denis Cook,
Designated Federal Official, DTAB, Division of Workplace Programs,
Center for Substance Abuse Prevention, Substance Abuse and Mental
Health Services Administration.
[FR Doc. 2013-01477 Filed 1-24-13; 8:45 am]
BILLING CODE 4162-20-P